Iphosphamide-induced nephrotoxicity in children
Authors:
- 1 March 1992
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 6 (2) , 162-165
Abstract
The nephrotoxic potential of iphosphamide was evaluated in a retrospective analysis of all children receiving the drug at The Hospital for Sick Children in Toronto. The 25 children exhibiting nephrotoxicity did not receive more cycles or higher doses per square metre than the 78 with normal renal function. Similarly, the two groups received comparable doses and number of cycles of sodium 2-mercaptoethanesulphonate, and had similar rates of exposure to nephrotoxic drugs (except forcis-platinum). Children exhibiting nephrotoxicity were significantly younger (78.1±64.1 months) than those having normal kidney function (103.8±66.6 months) (Pcis-platinum prior to the iphosphamide (10/25, 40%) than those with normal renal function (14/73, 18%) (Pcis-platinum.Keywords
This publication has 8 references indexed in Scilit:
- Nephrotoxicity after ifosfamide.Archives of Disease in Childhood, 1990
- Cyclophosphamide versus ifosfamide in paediatric oncologyThe Lancet, 1990
- Toxicity of high-dose ifosfamide in childrenCancer Chemotherapy and Pharmacology, 1989
- Hypophosphataemic rickets after ifosfamide treatment in children.BMJ, 1989
- Ifosfamide in pediatric malignancies.1989
- Fanconi syndrome after ifosfamideCancer Chemotherapy and Pharmacology, 1989
- POTENTIATION OF IFOSFAMIDE NEUROTOXICITY, HEMATOTOXICITY, AND TUBULAR NEPHROTOXICITY BY PRIOR CIS-DIAMMINEDICHLOROPLATINUM(II) THERAPY1987
- IFOSFAMIDE-INDUCED SUBCLINICAL TUBULAR NEPHROTOXICITY DESPITE MESNA1987